Literature DB >> 21708407

Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDS-registry.

Judith Neukirchen1, Wilma M Schoonen, Corinna Strupp, Norbert Gattermann, Carlo Aul, Rainer Haas, Ulrich Germing.   

Abstract

Population-based data on patients with MDS are scarce. Here we report the incidence and prevalence of MDS based on data from the Düsseldorf MDS Registry. Cases in the city of Düsseldorf in the study period were identified from the MDS Registry. We calculated crude, calendar-year, age- and sex-specific and European Standard Population age-standardized incidence rates as well as point prevalences per 100,000 The crude incidence rate was 4.15/100,000/year and the point prevalence per 100,000 persons of 7. We found that the incidence and prevalence of MDS was higher in men than women and increased sharply with increasing age. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21708407     DOI: 10.1016/j.leukres.2011.06.001

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  60 in total

1.  Population-based incidence of myeloid malignancies: fifteen years of epidemiological data in the province of Girona, Spain.

Authors:  Gemma Osca-Gelis; Montserrat Puig-Vives; Marc Saez; David Gallardo; Natalia Lloveras; Rafael Marcos-Gragera
Journal:  Haematologica       Date:  2013-06-28       Impact factor: 9.941

2.  Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes.

Authors:  Maryam Hejazi; Angela R Manser; Julia Fröbel; Andrea Kündgen; Xiaoyi Zhao; Kathrin Schönberg; Ulrich Germing; Rainer Haas; Norbert Gattermann; Markus Uhrberg
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

3.  Myelodysplastic Syndromes in the Elderly: Treatment Options and Personalized Management.

Authors:  Sonja Burgstaller; Petra Wiesinger; Reinhard Stauder
Journal:  Drugs Aging       Date:  2015-11       Impact factor: 3.923

4.  Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.

Authors:  Asma Ashraf; Andreas V Hadjinicolaou; Carolyn Doree; Sally Hopewell; Marialena Trivella; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2016-09-01

5.  Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic review.

Authors:  Michael Desborough; Lise J Estcourt; Anna Chaimani; Carolyn Doree; Sally Hopewell; Marialena Trivella; Andreas V Hadjinicolaou; Paresh Vyas; Simon J Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2016-01-26

Review 6.  Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders.

Authors:  Yisu Gu; Lise J Estcourt; Carolyn Doree; Sally Hopewell; Paresh Vyas
Journal:  Cochrane Database Syst Rev       Date:  2015-10-05

Review 7.  What's all the fuss about? facts and figures about bone marrow failure and conditions.

Authors:  Sudipto Mukherjee; Mikkael A Sekeres
Journal:  Curr Hematol Malig Rep       Date:  2012-12       Impact factor: 3.952

Review 8.  [Myelodysplastic syndromes. Epidemiology, molecular and morphological characteristics and risk stratification].

Authors:  A H Schmitt-Graeff; M J Müller; P Fisch
Journal:  Pathologe       Date:  2013-02       Impact factor: 1.011

Review 9.  The need for additional genetic markers for myelodysplastic syndrome stratification: what does the future hold for prognostication?

Authors:  Zaher K Otrock; Ramon V Tiu; Jaroslaw P Maciejewski; Mikkael A Sekeres
Journal:  Expert Rev Hematol       Date:  2013-02       Impact factor: 2.929

10.  A nationwide non-interventional epidemiological data registry on myelodysplastic syndromes in Lebanon.

Authors:  Zaher K Otrock; Nabil Chamseddine; Ziad M Salem; Tarek Wehbe; Mouna Al-Ayoubi; Moussa Dhaini; Joseph Kattan; Walid Mokaddem; Therese Abi Nasr; Oussama Jradi; Fadi S Farhat; Mahmoud Wehbe; Mohammad H Haidar; Mohamed A Kharfan-Dabaja; Nizar Bitar; Mirna El Hajj; Adel M Kadri; Francois G Kamar; Hanan Yassine; Hassan Khodr; Ali T Taher; Noha Hakime; Rami Ar Mahfouz; Wassim Serhal; Ali Bazarbachi; Hussein Z Farhat
Journal:  Am J Blood Res       Date:  2015-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.